Key result
Enhanced recovery pathways version 2.0 in thoracic surgery should focus on value in healthcare, defined as quality (longitudinal outcomes and quality of life) over comprehensive costs.
Answers are grounded in this paper and cite their sources.
Proposes a shift towards value-based healthcare in lung cancer surgery, defining value as longitudinal outcomes (survival, quality of life) over comprehensive costs (including social costs).
We need to move from the concept of outcomes to the one of values in healthcare. Value in healthcare is expressed by the equation quality over cost. Quality in lung cancer surgery is represented by longitudinal outcomes such as cancer specific survival and quality of life. When interpreted in this way, costs should not be limited to hospital costs, but include social costs. This should be the benchmark to evaluate our performance, the effectiveness of new technologies or lung cancer treatments, and finally of any process of care aimed at improving patient-centered values. This is what we mean for ERP version 2.
No takes yet. Share an insight, caveat, or question.
Brunelli et al. (2018) conducted an editorial in Lung cancer surgery. Enhanced recovery pathways version 2.0 was evaluated. Enhanced recovery pathways version 2.0 in thoracic surgery should focus on value in healthcare, defined as quality (longitudinal outcomes and quality of life) over comprehensive costs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: